Next Article in Journal
Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC
Next Article in Special Issue
Colorectal Cancer and Purinergic Signalling: An Overview
Previous Article in Journal
Updates in the Use of BCL-2-Family Small Molecule Inhibitors for the Treatment of Relapsed/Refractory Multiple Myeloma
Previous Article in Special Issue
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma
 
 
Review

Article Versions Notes

Cancers 2022, 14(14), 3331; https://doi.org/10.3390/cancers14143331
Action Date Notes Link
article xml file uploaded 8 July 2022 11:08 CEST Original file -
article xml uploaded. 8 July 2022 11:08 CEST Update https://www.mdpi.com/2072-6694/14/14/3331/xml
article pdf uploaded. 8 July 2022 11:08 CEST Version of Record https://www.mdpi.com/2072-6694/14/14/3331/pdf
article html file updated 8 July 2022 11:10 CEST Original file -
article html file updated 13 August 2022 00:48 CEST Update https://www.mdpi.com/2072-6694/14/14/3331/html
Back to TopTop